These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38328370)

  • 1. Assessment of the gradient diffusion method for fosfomycin susceptibility testing in
    Jariyapamornkoon N; Boonkam P; Suanpairintr N
    Vet World; 2023 Dec; 16(12):2497-2503. PubMed ID: 38328370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter Evaluation of the Novel ETEST Fosfomycin for Antimicrobial Susceptibility Testing of Enterobacterales, Enterococcus faecalis, and Staphylococcus Species.
    Goer A; Blanchard LS; Van Belkum A; Loftus KJ; Armstrong TP; Gatermann SG; Shortridge D; Olson BJ; Meece JK; Fritsche TR; Pompilio M; Halimi D; Franceschi C
    J Clin Microbiol; 2022 Jul; 60(7):e0002122. PubMed ID: 35736011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Fosfomycin Etest To Determine
    Karlowsky JA; Baxter MR; Golden AR; Adam HJ; Walkty A; Lagacé-Wiens PRS; Zhanel GG
    J Clin Microbiol; 2021 Nov; 59(12):e0163521. PubMed ID: 34495708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of Vitek 2 for antimicrobial susceptibility testing of Staphylococcus spp. and Enterococcus spp.
    Bobenchik AM; Hindler JA; Giltner CL; Saeki S; Humphries RM
    J Clin Microbiol; 2014 Feb; 52(2):392-7. PubMed ID: 24478467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of agar dilution, broth microdilution, E-test, disk diffusion, and automated Vitek methods for testing susceptibilities of Enterococcus spp. to vancomycin.
    Kohner PC; Patel R; Uhl JR; Garin KM; Hopkins MK; Wegener LT; Cockerill FR
    J Clin Microbiol; 1997 Dec; 35(12):3258-63. PubMed ID: 9399530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the Susceptibility of Clinical Gram-Negative and Gram-Positive Bacterial Strains to Fosfomycin and Significance of This Antibiotic in Infection Treatment.
    Kowalska-Krochmal B; Mączyńska B; Rurańska-Smutnicka D; Secewicz A; Krochmal G; Bartelak M; Górzyńska A; Laufer K; Woronowicz K; Łubniewska J; Łappo J; Czwartos M; Dudek-Wicher R
    Pathogens; 2022 Nov; 11(12):. PubMed ID: 36558775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates.
    Hirsch EB; Raux BR; Zucchi PC; Kim Y; McCoy C; Kirby JE; Wright SB; Eliopoulos GM
    Int J Antimicrob Agents; 2015 Dec; 46(6):642-7. PubMed ID: 26498988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of Fosfomycin Susceptibility in Extended Spectrum Beta-Lactamase Producing Enteric Bacteria by Disk Diffusion, Automated System and Agar Dilütion Kit].
    Soydan G; Görgülü Y; Öztürk C
    Mikrobiyol Bul; 2021 Oct; 55(4):617-625. PubMed ID: 34666660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of Clinical Isolates of Escherichia coli to Fosfomycin as Measured by Four
    Karlowsky JA; Lagacé-Wiens PRS; Laing NM; Baxter MR; Adam HJ; Zhanel GG
    J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32817224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fosfomycin Susceptibility Testing Using Commercial Agar Dilution Test.
    Croughs PD; Konijnendijk-de Regt M; Yusuf E
    Microbiol Spectr; 2022 Apr; 10(2):e0250421. PubMed ID: 35352940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gold standard susceptibility testing of fosfomycin in Staphylococcus aureus and Enterobacterales using a new agar dilution panel®.
    Campanile F; Wootton M; Davies L; Aprile A; Mirabile A; Pomponio S; Demetrio F; Bongiorno D; Walsh TR; Stefani S; Mezzatesta ML
    J Glob Antimicrob Resist; 2020 Dec; 23():334-337. PubMed ID: 33127523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gradient diffusion susceptibility testing for
    Desjardins M; Lefebvre B; Lavallée C; Labbé AC; Mauffrey F; Martin I; Longtin J; Fortin C
    Access Microbiol; 2020; 2(5):acmi000116. PubMed ID: 32974579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic susceptibility testing (agar disk diffusion and agar dilution) of clinical isolates of Enterococcus faecalis and E. faecium: comparison of Mueller-Hinton, Iso-Sensitest, and Wilkins-Chalgren agar media.
    Traub WH; Geipel U; Leonhard B
    Chemotherapy; 1998; 44(4):217-29. PubMed ID: 9681198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proficiency of Italian clinical laboratories in detecting reduced glycopeptide susceptibility in Enterococcus and Staphylococcus spp. using routine laboratory methodologies.
    Jones ME; Gesu G; Ortisi G; Sahm DF; Critchley IA; Goglio A;
    Clin Microbiol Infect; 2002 Feb; 8(2):101-11. PubMed ID: 11952723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Performances of Vitek-2, Disk Diffusion, and Broth Microdilution for Antimicrobial Susceptibility Testing of Canine Staphylococcus pseudintermedius.
    Rampacci E; Trotta M; Fani C; Silvestri S; Stefanetti V; Brachelente C; Mencacci A; Passamonti F
    J Clin Microbiol; 2021 Aug; 59(9):e0034921. PubMed ID: 34132581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of M.I.C.E. and Etest with CLSI agar dilution for antimicrobial susceptibility testing against oxacillin-resistant Staphylococcus spp.
    Campana EH; Carvalhaes CG; Nonato B; Machado AM; Gales AC
    PLoS One; 2014; 9(4):e94627. PubMed ID: 24732297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycopeptide resistance in Enterococcus spp. and coagulase-negative staphylococci from hospitalised patients in Germany: occurrence, characteristics and dalbavancin susceptibility.
    Kresken M; Klare I; Wichelhaus TA; Wohlfarth E; Layer-Nicolaou F; Neumann B; Werner G;
    J Glob Antimicrob Resist; 2022 Mar; 28():102-107. PubMed ID: 34958996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid detection of fosfomycin resistance in Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections.
    Kansak N; Arıcı N; Adaleti R; Nakipoglu Y; Aksaray S
    J Microbiol Methods; 2021 Sep; 188():106296. PubMed ID: 34333048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities of Eravacycline, Tedizolid, Norvancomycin, Nemonoxacin, Ceftaroline, and Comparators against 1,871
    Ding L; Yang Y; Zheng C; Sun G; Han R; Guo Y; Yin D; Wu S; Zhu D; Hu F
    Microbiol Spectr; 2022 Dec; 10(6):e0171522. PubMed ID: 36326536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter Clinical Evaluation of ETEST Eravacycline for Susceptibility Testing of
    Blanchard LS; Armstrong TP; Kresken M; Emery CL; Ying YX; Sauvonnet V; Zambardi G
    J Clin Microbiol; 2023 Mar; 61(3):e0165022. PubMed ID: 36877080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.